Pfizer

48
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,999.00
-3.8 (-0.08%)
BSENSE

Dec 05

BSE+NSE Vol: 2.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Pfizer Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Nov'08
Nov'07
No of Months
12
12
Profit Before Tax
211.22
468.69
Adjustment
-49.50
-298.39
Changes In working Capital
-7.89
-33.38
Cash Flow after changes in Working Capital
153.82
136.91
Cash Flow from Operating Activities
237.76
16.63
Cash Flow from Investing Activities
-78.87
232.34
Cash Flow from Financing Activities
-95.19
-75.89
Net Cash Inflow / Outflow
63.69
173.08
Opening Cash & Cash Equivalents
479.91
306.82
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
Closing Cash & Cash Equivalent
543.60
479.91
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Pfizer
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
21122.06
-16
21,138.00
132112.88%
Adjustment
-4950
455
-5,405.00
-1187.91%
Changes In working Capital
-789.18
-492
-297.00
-60.40%
Cash Flow after changes in Working Capital
15382.88
-53
15,435.00
29124.30%
Cash Flow from Operating Activities
23776.26
-22
23,798.00
108173.91%
Cash Flow from Investing Activities
-7887.35
-780
-7,107.00
-911.20%
Cash Flow from Financing Activities
-9519.58
409
-9,928.00
-2427.53%
Net Cash Inflow / Outflow
6369.33
-393
6,762.00
1720.69%
Opening Cash & Cash Equivalents
47991.26
505
47,486.00
9403.22%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
54360.59
112
54,248.00
48436.24%
Cash Flow - Snapshot (Standalone) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 156.87% vs -27.79% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
659.75
256.84
156.87%